• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Wearable sweat sensor pioneer issued key device patent

Bioengineer by Bioengineer
December 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Invention by Dr. Jason Heikenfeld provides chronological assurance of sweat analyte data

December 18, 2018. Cincinnati, Ohio. Eccrine Systems, Inc., an advanced sweat sensor company, today announced that a key patent, US10136831, has been issued to Dr. Jason Heikenfeld, Co-Founder & CSO, and prominent University of Cincinnati researcher. The company holds exclusive rights to the UC patent.

The patented invention covers the use of on-body sweat devices that are capable of electronically correlating two or more measurements of an analyte with the time at which the analyte emerged in newly excreted sweat. Without the use of the invention it is likely not possible to correlate sweat analyte data trends with chronological blood values or similar physiological measurements. Heikenfeld developed his invention over four years ago at a time when continuous on-body measurement of sweat analytes was at its inception. Heikenfeld is a well-known scientific leader of the wearable sweat sensor space with many of its most prescient and important advances to his credit.

The company uses Heikenfeld’s invention to time correlate the data derived from its sweat sensor devices, including data and algorithms that will define the pharmacokinetic (PK) profile of medications that are excreted in locally stimulated sweat. “Non-invasive medication monitoring is a great example of the utility of Jason’s invention,” says Dr. Gavi Begtrup, CEO of Eccrine Systems. “You can’t devise an on-body device to derive a sweat pharmacokinetic curve, and then correlate that curve to a drug’s blood PK curve, without using this invention. This is a big deal given the estimated $500 billion dollar annual healthcare cost of non-optimized medication therapy, a significant portion of which can result from individual PK differences that cause failed treatment outcomes.”

###

About Eccrine Systems, Inc.

Eccrine Systems is a privately held company dedicated to improving human health, safety, and productivity through the innovation and development of advanced sweat sensing technologies. The Cincinnati-based company was founded in 2013 to commercialize technology and intellectual property that was exclusively licensed from the University of Cincinnati, and with the funding support of CincyTech and its network of local, regional and national investment sources. To learn more, please visit http://www.eccrinesystems.com.

Trademarks

Eccrine Systems and the company logo image are registered trademarks of Eccrine Systems, Inc.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements about Eccrine Systems, Inc. These forward-looking statements are based upon the company’s current expectations and projections about future events and generally relate to the company’s plans, objectives and expectations for the development of its business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

Contacts

Eccrine Systems, Inc.

Evyn White, 513-214-1659

[email protected]

Media Contact
Evyn White
[email protected]
513-214-1659
https://www.businesswire.com/news/home/20181218005089/en/Wearable-Sweat-Sensor-Pioneer-Issued-Key-Device

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyElectrical Engineering/ElectronicsMedicine/HealthResearch/DevelopmentResearchers/Scientists/Awards
Share12Tweet8Share2ShareShareShare2

Related Posts

Engaging Families in Advance Care Planning: A Study

October 6, 2025
blank

Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors

October 6, 2025

Mycoplasma Pneumoniae Linked to Neuromyelitis Optica Case

October 6, 2025

Innovative Modeling for Transcriptomics in FFPE Samples

October 6, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Engaging Families in Advance Care Planning: A Study

N6-methyladenosine Enhances Pork Muscle Quality via Myofiber Regulation

Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.